Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-002611
Accepted
2023-09-11 00:15:30
Documents
1
Effectiveness Date
2023-09-08
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 602
  Complete submission text file 9999999995-23-002611.txt   1831
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-274246 | Film No.: 231246560
SIC: 2835 In Vitro & In Vivo Diagnostic Substances